N1-methylpseudouridine enhances immunogenicity of RNA/lipidnanoparticle vaccines targeting SARS-CoV-2 spike and the model antigen ovalbumin
- DOI
- 10.5061/dryad.g79cnp64d
- Published
- 2026
- Container
- Not recorded
- Publisher
- Dryad
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/publicdomain/zero/1.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5061/dryad.g79cnp64d,
title = {N1-methylpseudouridine enhances immunogenicity of RNA/lipidnanoparticle vaccines targeting SARS-CoV-2 spike and the model antigen ovalbumin},
author = {Akache, Bassel and Azizi, Hiva and Renner, Tyler M and Agbayani, Gerard and Dudani, Renu and Harrison, Blair A and Rossotti, Martin A and Tanha, Jamshid and McCluskie, Michael J and Stark, Felicity C},
year = {2026},
doi = {10.5061/dryad.g79cnp64d},
url = {https://doi.org/10.5061/dryad.g79cnp64d}
}RIS
TY - JOUR TI - N1-methylpseudouridine enhances immunogenicity of RNA/lipidnanoparticle vaccines targeting SARS-CoV-2 spike and the model antigen ovalbumin AU - Akache, Bassel AU - Azizi, Hiva AU - Renner, Tyler M AU - Agbayani, Gerard AU - Dudani, Renu AU - Harrison, Blair A AU - Rossotti, Martin A AU - Tanha, Jamshid AU - McCluskie, Michael J AU - Stark, Felicity C PY - 2026 DO - 10.5061/dryad.g79cnp64d UR - https://doi.org/10.5061/dryad.g79cnp64d ER -
APA
Bassel, A., Hiva, A., M, R. T., Gerard, A., Renu, D., A, H. B., A, R. M., Jamshid, T., J, M. M., & C, S. F. (2026). N1-methylpseudouridine enhances immunogenicity of RNA/lipidnanoparticle vaccines targeting SARS-CoV-2 spike and the model antigen ovalbumin. https://doi.org/10.5061/dryad.g79cnp64d
Source records
- datacite · retrieved 2026-11-06T22:13:03.490Z